Alkyl citrate precursors

Alkyl citrate precursors, also known as alkyl citrate natural products or squalestatins, represent a structurally distinct class of secondary fungal metabolites characterized by a highly oxidized citric acid core attached to varied alkyl chains. These molecules are not considered a single biological target but are pharmacological agents that act as potent inhibitors of key enzymes in the lipid biosynthetic pathway, most notably squalene synthase (FDFT1) and ATP-citrate lyase (ACLY). Squalene synthase is the first committed step in the synthesis of sterols, such as cholesterol in humans and ergosterol in fungi, making these precursors significant leads for the treatment of hypercholesterolemia and systemic fungal infections. The most prominent members of this family are the zaragozic acids, which exhibit sub-nanomolar potency by mimicking the substrate/intermediate structure of the squalene synthase reaction. In human medicine, the synthetic alkyl citrate-like prodrug bempedoic acid is used to inhibit ATP-citrate lyase, effectively lowering LDL cholesterol levels. Despite their potency, the therapeutic development of natural alkyl citrates has been historically hindered by their complex chemical synthesis and potential for off-target effects on other citrate-utilizing metabolic enzymes.

Other names

Alkyl citratesSqualestatinsZaragozic acidsSqualene synthase inhibitorsCitrate analogsCitrate-based secondary metabolites

Inhibition of squalene synthase (FDFT1) and ATP-citrate lyase (ACLY) through structural mimicry of citrate or its metabolic intermediates, resulting in the competitive or non-competitive blockade of the lipid biosynthetic pathway.